| Product Code: ETC7214653 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Cannabis Medicine Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Cannabis Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 France Cannabis Medicine Market - Industry Life Cycle |
3.4 France Cannabis Medicine Market - Porter's Five Forces |
3.5 France Cannabis Medicine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 France Cannabis Medicine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 France Cannabis Medicine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 France Cannabis Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing acceptance of medical cannabis for various health conditions in France |
4.2.2 Growing awareness among healthcare professionals and patients about the potential benefits of cannabis medicine |
4.2.3 Favorable regulatory environment and evolving legislation supporting the use of medical cannabis in France |
4.3 Market Restraints |
4.3.1 Limited availability and accessibility of medical cannabis products in the French market |
4.3.2 High cost associated with medical cannabis treatment and lack of reimbursement by health insurance |
4.3.3 Stigma and social barriers surrounding the use of cannabis for medical purposes in France |
5 France Cannabis Medicine Market Trends |
6 France Cannabis Medicine Market, By Types |
6.1 France Cannabis Medicine Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 France Cannabis Medicine Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 France Cannabis Medicine Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.1.4 France Cannabis Medicine Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.2 France Cannabis Medicine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 France Cannabis Medicine Market Revenues & Volume, By Chronic Pain, 2021- 2031F |
6.2.3 France Cannabis Medicine Market Revenues & Volume, By Mental Disorders, 2021- 2031F |
6.2.4 France Cannabis Medicine Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3 France Cannabis Medicine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 France Cannabis Medicine Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 France Cannabis Medicine Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 France Cannabis Medicine Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 France Cannabis Medicine Market Import-Export Trade Statistics |
7.1 France Cannabis Medicine Market Export to Major Countries |
7.2 France Cannabis Medicine Market Imports from Major Countries |
8 France Cannabis Medicine Market Key Performance Indicators |
8.1 Number of licensed healthcare professionals prescribing cannabis medicine in France |
8.2 Patient satisfaction and reported improvement in health outcomes after using cannabis medicine |
8.3 Research and development investments in cannabis-based pharmaceuticals in France |
9 France Cannabis Medicine Market - Opportunity Assessment |
9.1 France Cannabis Medicine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 France Cannabis Medicine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 France Cannabis Medicine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 France Cannabis Medicine Market - Competitive Landscape |
10.1 France Cannabis Medicine Market Revenue Share, By Companies, 2024 |
10.2 France Cannabis Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here